Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2013, Article ID 412576, 11 pages
http://dx.doi.org/10.1155/2013/412576
Research Article

Curcumin Protects Human Keratinocytes against Inorganic Arsenite-Induced Acute Cytotoxicity through an NRF2-Dependent Mechanism

1Department of Forensic Pathology, School of Forensic Medicine, China Medical University, Shenyang , Liaoning 110001, China
2Institute for Chemical Safety Sciences, The Hamner Institutes for Health Sciences, Research Triangle Park, NC 27709-2137, USA
3Department of Histology and Embryology, School of Basic Medicine, China Medical University, Shenyang, Liaoning 110001, China
4Department of Infectious Diseases, The First Affiliated Hospital, China Medical University, Shenyang, Liaoning 110001, China

Received 5 February 2013; Accepted 18 March 2013

Academic Editor: Hye-Youn Cho

Copyright © 2013 Rui Zhao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Pi, Y. Kumagai, G. Sun et al., “Decreased serum concentrations of nitric oxide metabolites among Chinese in an endemic area of chronic arsenic poisoning in inner Mongolia,” Free Radical Biology and Medicine, vol. 28, no. 7, pp. 1137–1142, 2000. View at Publisher · View at Google Scholar · View at Scopus
  2. T. Yoshida, H. Yamauchi, and G. Fan Sun, “Chronic health effects in people exposed to arsenic via the drinking water: dose-response relationships in review,” Toxicology and Applied Pharmacology, vol. 198, no. 3, pp. 243–252, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. S. S. Wong, K. C. Tan, and C. L. Goh, “Cutaneous manifestations of chronic arsenicism: review of seventeen cases,” Journal of the American Academy of Dermatology, vol. 38, no. 2, pp. 179–185, 1998. View at Publisher · View at Google Scholar · View at Scopus
  4. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, “Some drinking-water disinfectants and contaminants, including arsenic,” IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol. 84, pp. 1–477, 2004. View at Google Scholar
  5. J. Pi, H. Yamauchi, Y. Kumagai et al., “Evidence for induction of oxidative stress caused by chronic exposure of Chinese residents to arsenic contained in drinking water,” Environmental Health Perspectives, vol. 110, no. 4, pp. 331–336, 2002. View at Google Scholar · View at Scopus
  6. J. Pi, W. Qu, J. M. Reece, Y. Kumagai, and M. P. Waalkes, “Transcription factor Nrf2 activation by inorganic arsenic in cultured keratinocytes: involvement of hydrogen peroxide,” Experimental Cell Research, vol. 290, no. 2, pp. 234–245, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Zhao, Y. Hou, P. Xue et al., “Long isoforms of NRF1 contribute to arsenic-induced antioxidant response in human keratinocytes,” Environmental Health Perspectives, vol. 119, no. 1, pp. 56–62, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. R. Zhao, Y. Hou, Q. Zhang et al., “Cross-regulations among NRFs and KEAP1 and effects of their silencing on arsenic-induced antioxidant response and cytotoxicity in human keratinocytes,” Environmental Health Perspectives, vol. 120, pp. 583–589, 2012. View at Google Scholar
  9. M. Biswas and J. Y. Chan, “Role of Nrf1 in antioxidant response element-mediated gene expression and beyond,” Toxicology and Applied Pharmacology, vol. 244, no. 1, pp. 16–20, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. J. D. Hayes and M. McMahon, “NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer,” Trends in Biochemical Sciences, vol. 34, no. 4, pp. 176–188, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Aono, T. Yanagawa, K. Itoh et al., “Activation of Nrf2 and accumulation of ubiquitinated A170 by arsenic in osteoblasts,” Biochemical and Biophysical Research Communications, vol. 305, no. 2, pp. 271–277, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Zhou, C. S. Beevers, and S. Huang, “The targets of curcumin,” Current Drug Targets, vol. 12, no. 3, pp. 332–347, 2011. View at Google Scholar · View at Scopus
  13. Y. Mano, T. Usui, and H. Kamimura, “In vitro inhibitory effects of non-steroidal anti-inflammatory drugs on 4-methylumbelliferone glucuronidation in recombinant human UDP-glucuronosyltransferase 1A9—potent inhibition by niflumic acid,” Biopharmaceutics and Drug Disposition, vol. 27, no. 1, pp. 1–6, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. C. S. Divya and M. R. Pillai, “Antitumor action of curcumin in human papillomavirus associated cells involves downregulation of viral oncogenes, prevention of NFkB and AP-1 translocation, and modulation of apoptosis,” Molecular Carcinogenesis, vol. 45, no. 5, pp. 320–332, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Rukkumani, K. Aruna, P. S. Varma, and V. P. Menon, “Curcumin influences hepatic expression patterns of matrix metalloproteinases in liver toxicity,” The Italian Journal of Biochemistry, vol. 53, no. 2, pp. 61–66, 2004. View at Google Scholar · View at Scopus
  16. H. Wang, Q. R. Geng, L. Wang, and Y. Lu, “Curcumin potentiates antitumor activity of L-asparaginase via inhibition of the AKT signaling pathway in acute lymphoblastic leukemia,” Leukemia & Lymphoma, vol. 53, pp. 1376–1382.
  17. G. S. Jeong, G. S. Oh, H. O. Pae et al., “Comparative effects of curcuminoids on endothelial heme oxygenase-1 expression: ortho-methoxy groups are essential to enhance heme oxygenase activity and protection,” Experimental and Molecular Medicine, vol. 38, no. 4, pp. 393–400, 2006. View at Google Scholar · View at Scopus
  18. E. Balogun, R. Foresti, C. J. Green, and R. Motterlini, “Changes in temperature modulate heme oxygenase-1 induction by curcumin in renal epithelial cells,” Biochemical and Biophysical Research Communications, vol. 308, no. 4, pp. 950–955, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. G. Scapagnini, R. Foresti, V. Calabrese, A. M. Giuffrida Stella, C. J. Green, and R. Motterlini, “Caffeic acid phenethyl ester and curcumin: a novel class of heme oxygenase-1 inducers,” Molecular Pharmacology, vol. 61, no. 5, pp. 554–561, 2002. View at Google Scholar
  20. S. Khan, J. A. Vala, S. U. Nabi et al., “Protective effect of curcumin against arsenic-induced apoptosis in murine splenocytes in vitro,” Journal of Immunotoxicology, vol. 9, pp. 148–159.
  21. E. O. Farombi, S. Shrotriya, H. K. Na, S. H. Kim, and Y. J. Surh, “Curcumin attenuates dimethylnitrosamine-induced liver injury in rats through Nrf2-mediated induction of heme oxygenase-1,” Food and Chemical Toxicology, vol. 46, no. 4, pp. 1279–1287, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. R. D. Lele, “Beyond reverse pharmacology: mechanism-based screening of Ayurvedic drugs,” Journal of Ayurveda and Integrative Medicine, vol. 1, no. 4, pp. 257–265, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Yadav, V. Lomash, M. Samim, and S. J. Flora, “Curcumin encapsulated in chitosan nanoparticles: a novel strategy for the treatment of arsenic toxicity,” Chemico-Biological Interactions, vol. 199, pp. 49–61, 2012. View at Google Scholar
  24. J. Biswas, S. Roy, S. Mukherjee, D. Sinha, and M. Roy, “Indian spice curcumin may be an effective strategy to combat the genotoxicity of arsenic in Swiss albino mice,” Asian Pacific Journal of Cancer Prevention, vol. 11, no. 1, pp. 239–247, 2010. View at Google Scholar · View at Scopus
  25. R. S. Yadav, R. K. Shukla, M. L. Sankhwar et al., “Neuroprotective effect of curcumin in arsenic-induced neurotoxicity in rats,” NeuroToxicology, vol. 31, no. 5, pp. 533–539, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. N. Suwannateep, S. Wanichwecharungruang, S. F. Haag et al., “Encapsulated curcumin results in prolonged curcumin activity in vitro and radical scavenging activity ex vivo on skin after UVB-irradiation,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 82, pp. 485–490, 2012. View at Google Scholar
  27. R. S. Yadav, M. L. Sankhwar, R. K. Shukla et al., “Attenuation of arsenic neurotoxicity by curcumin in rats,” Toxicology and Applied Pharmacology, vol. 240, no. 3, pp. 367–376, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. M. McMahon, K. Itoh, M. Yamamoto et al., “The cap “n” collar basic leucine zipper transcription factor Nrf2 (NF-E2 p45-related factor 2) controls both constitutive and inducible expression of intestinal detoxification and glutathione biosynthetic enzymes,” Cancer Research, vol. 61, no. 8, pp. 3299–3307, 2001. View at Google Scholar · View at Scopus
  29. S. A. Reisman, I. I. Csanaky, L. M. Aleksunes, and C. D. Klaassen, “Altered disposition of acetaminophen in Nrf2-null and keap1-knockdown mice,” Toxicological Sciences, vol. 109, no. 1, pp. 31–40, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. K. Brzóska, T. M. Stepkowski, and M. Kruszewski, “Putative proto-oncogene pir expression is significantly up-regulated in the spleen and kidney of cytosolic superoxide dismutase-deficient mice,” Redox Report, vol. 16, no. 3, pp. 129–133, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. X. F. Guo, X. F. Zhu, G. S. Zhong, and B. G. Deng, “Retracted: lapatinib, a dual inhibitor of epidermal growth factor receptor and human epidermal growth factor receptor 2, potentiates the antitumor effects of cisplatin on esophageal carcinoma,” Diseases of the Esophagus, 2012. View at Publisher · View at Google Scholar
  32. S. O. Jeong, G. S. Oh, H. Y. Ha et al., “Dimethoxycurcumin, a synthetic curcumin analogue, induces heme oxygenase-1 expression through Nrf2 activation in RAW264.7 macrophages,” Journal of Clinical Biochemistry and Nutrition, vol. 44, no. 1, pp. 79–84, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. T. Nishinaka, Y. Ichijo, M. Ito et al., “Curcumin activates human glutathione S-transferase P1 expression through antioxidant response element,” Toxicology Letters, vol. 170, no. 3, pp. 238–247, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. Y. Du, N. F. Villeneuve, X. J. Wang et al., “Oridonin confers protection against arsenic-induced toxicity through activation of the Nrf2-mediated defensive response,” Environmental Health Perspectives, vol. 116, no. 9, pp. 1154–1161, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. R. L. Thangapazham, A. Sharma, and R. K. Maheshwari, “Beneficial role of curcumin in skin diseases,” Advances in Experimental Medicine and Biology, vol. 595, pp. 343–357, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Kulac, C. Aktas, F. Tulubas et al., “The effects of topical treatment with curcumin on burn wound healing in rats,” Journal of Molecular Histology, vol. 44, no. 1, pp. 83–90, 2013. View at Google Scholar
  37. M. C. Y. Heng, “Curcumin targeted signaling pathways: basis for anti-photoaging and anti-carcinogenic therapy,” International Journal of Dermatology, vol. 49, no. 6, pp. 608–622, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. C. Yang, X. Zhang, H. Fan, and Y. Liu, “Curcumin upregulates transcription factor Nrf2, HO-1 expression and protects rat brains against focal ischemia,” Brain Research, vol. 1282, pp. 133–141, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. H. Hatcher, R. Planalp, J. Cho, F. M. Torti, and S. V. Torti, “Curcumin: from ancient medicine to current clinical trials,” Cellular and Molecular Life Sciences, vol. 65, no. 11, pp. 1631–1652, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. S. A. Rushworth, R. M. Ogborne, C. A. Charalambos, and M. A. O'Connell, “Role of protein kinase C δ in curcumin-induced antioxidant response element-mediated gene expression in human monocytes,” Biochemical and Biophysical Research Communications, vol. 341, no. 4, pp. 1007–1016, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. V. T. Natarajan, A. Singh, A. A. Kumar et al., “Transcriptional upregulation of Nrf2-dependent phase II detoxification genes in the involved epidermis of vitiligo vulgaris,” The Journal of Investigative Dermatology, vol. 130, no. 12, pp. 2781–2789, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. A. Banning, S. Deubel, D. Kluth, Z. Zhou, and R. Brigelius-Flohé, “The GI-GPx gene is a target for Nrf2,” Molecular and Cellular Biology, vol. 25, no. 12, pp. 4914–4923, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. S. J. McNally, E. M. Harrison, J. A. Ross, O. J. Garden, and S. J. Wigmore, “Curcumin induces heme oxygenase 1 through generation of reactive oxygen species, p38 activation and phosphatase inhibition,” International Journal of Molecular Medicine, vol. 19, no. 1, pp. 165–172, 2007. View at Google Scholar · View at Scopus
  44. S. Kossler, C. Nofziger, M. Jakab, S. Dossena, and M. Paulmichl, “Curcumin affects cell survival and cell volume regulation in human renal and intestinal cells,” Toxicology, vol. 292, pp. 123–135, 2012. View at Google Scholar
  45. J. Dujic, S. Kippenberger, S. Hoffmann et al., “Low concentrations of curcumin induce growth arrest and apoptosis in skin keratinocytes only in combination with UVA or visible light,” The Journal of Investigative Dermatology, vol. 127, no. 8, pp. 1992–2000, 2007. View at Publisher · View at Google Scholar · View at Scopus
  46. D. Chendil, R. S. Ranga, D. Meigooni, S. Sathishkumar, and M. M. Ahmed, “Curcumin confers radiosensitizing effect in prostate cancer cell line PC-3,” Oncogene, vol. 23, no. 8, pp. 1599–1607, 2004. View at Publisher · View at Google Scholar · View at Scopus
  47. J. Pi, Y. He, C. Bortner et al., “Low level, long-term inorganic arsenite exposure causes generalized resistance to apoptosis in cultured human keratinocytes: potential role in skin co-carcinogenesis,” International Journal of Cancer, vol. 116, no. 1, pp. 20–26, 2005. View at Publisher · View at Google Scholar · View at Scopus
  48. R. M. Perera and N. Bardeesy, “Cancer: When antioxidants are bad,” Nature, vol. 475, no. 7354, pp. 43–44, 2011. View at Publisher · View at Google Scholar · View at Scopus
  49. R. Costa, H. Abdulhaq, B. Haq et al., “Activity of azacitidine in chronic myelomonocytic leukemia,” Cancer, vol. 117, no. 12, pp. 2690–2696, 2011. View at Publisher · View at Google Scholar · View at Scopus
  50. J. D. Hayes and M. McMahon, “The double-edged sword of Nrf2: subversion of redox homeostasis during the evolution of cancer,” Molecular Cell, vol. 21, no. 6, pp. 732–734, 2006. View at Publisher · View at Google Scholar · View at Scopus
  51. X. J. Wang, Z. Sun, W. Chen, K. E. Eblin, J. A. Gandolfi, and D. D. Zhang, “Nrf2 protects human bladder urothelial cells from arsenite and monomethylarsonous acid toxicity,” Toxicology and Applied Pharmacology, vol. 225, no. 2, pp. 206–213, 2007. View at Publisher · View at Google Scholar · View at Scopus
  52. L. Marrot, C. Jones, P. Perez, and J. R. Meunier, “The significance of Nrf2 pathway in (photo)-oxidative stress response in melanocytes and keratinocytes of the human epidermis,” Pigment Cell and Melanoma Research, vol. 21, no. 1, pp. 79–88, 2008. View at Publisher · View at Google Scholar · View at Scopus
  53. Y. Shinkai, D. Sumi, I. Fukami, T. Ishii, and Y. Kumagai, “Sulforaphane, an activator of Nrf2, suppresses cellular accumulation of arsenic and its cytotoxicity in primary mouse hepatocytes,” FEBS Letters, vol. 580, no. 7, pp. 1771–1774, 2006. View at Publisher · View at Google Scholar · View at Scopus
  54. J. Y. Chan, M. Kwong, R. Lu et al., “Targeted disruption of the ubiquitous CNC-bZIP transcription factor, Nrf-1, results in anemia and embryonic lethality in mice,” The EMBO Journal, vol. 17, no. 6, pp. 1779–1787, 1998. View at Publisher · View at Google Scholar · View at Scopus
  55. Y. Zhang and J. D. Hayes, “Identification of topological determinants in the N-terminal domain of transcription factor Nrf1 that control its orientation in the endoplasmic reticulum membrane,” Biochemical Journal, vol. 430, no. 3, pp. 497–510, 2010. View at Publisher · View at Google Scholar · View at Scopus